-
Continue reading →: AMD Just Flipped the Script on AI: A 70% Price Hike That Could Change EverythingAMD’s rumored 70% price jump for its Instinct MI350 AI chips—from $15,000 to around $25,000—is a real-time signal that AMD is evolving from being just a chip supplier to a full-scale AI compute platform player. This shift lines up with several of the core arguments in our thesis and adds…
-
Continue reading →: The Quiet Rotation: Why Smart Money Is Slowly Pivoting From Nvidia to AMDThis piece will be divided into two parts. In this first section, I’ll walk through the technical case for a potential relative strength rotation from NVIDIA to AMD. In the second, I’ll unpack the underlying tech and business dynamics that could be driving this shift. With no further ado, let’s…
-
Continue reading →: IOVA Is Waking Up — Price Action Screams Breakout, But Fundamentals Demand Patience
IOVA is breaking out hard—and it’s not just noise. This move is coming off a multi-month base with serious volume behind it. The most recent candle? A textbook marubozu, meaning it closed strong near the highs. That came right after a clean upside range expansion, and the previous session wasn’t…
-
Continue reading →: Bad Quarter, Big Vision: Tesla’s Worst Metrics Hide The AI Supercycle UnleashRevenue slid 12% from a year ago to $22.5 billion. Not a surprise, considering the drop in vehicle deliveries and softer selling prices across the board. Gross margin came in at 17.2%—down 71 basis points. There were some cost savings from materials and model mix, but they couldn’t fully counter…
-
Continue reading →: PacBio: The Shift To Razor-Blade Economics Could Be A Game ChangerI have written about Pacific Biosciences (PACB) multiple times before. In my last analysis, I stated that the convertible debt the company issued would likely drag the stock. However, now that the company has broken through the $1 level that avoids Nasdaq delisting for now, we can focus on what…
-
Continue reading →: Opendoor’s Run Looks Like a Dead Cat Bounce—But the Business Says OtherwiseThe rally in Opendoor (OPEN) comes on the heels of a long, grinding decline, and that backdrop really changes how this move should be viewed. After extended downtrends, sharp upside moves aren’t unusual—they can be either classic “dead-cat bounces” or the start of real trend reversals. Over the last 3–5…
-
Continue reading →: Thoughts on The Most Likely Endgame for Layer‑1 BlockchainsGiven the patterns for tech adoption, what is the the most likely outcome for adoption in L1s? This is a sharp question because tech adoption — like Layer‑1 blockchains, AI models, or financial rails — rarely follows a neat, predictable curve. Instead, it’s usually a messy mix of network effects,…
-
Continue reading →: Rilparencel De-Risks Phase 3 as ProKidney Enters Price DiscoveryProKidney Corp just caught my attention with a massive green day. This action is backed by clinical results that the market took with huge enthusiasm. Let’s take a deep dive on the price action. Technical read The latest price action shows a massive Marubozu candle—no upper or lower wicks, just…
-
Continue reading →: PACB Technical Outlook: Box Breakout, Momentum Run, Key Fib Targets AheadPacific Bio (PACB) has been dormant for a long time. Now the price action seems to be getting interesting. It deserves a deepdive. Candlestick analysis The last three daily candles paint a clear bullish continuation story. Each session closed strong, with large green bodies that finished near their highs and…
Hi Fren,
Pepe Maltese
I used to trade inside the machine. Now I just raid it.
I publish two high-conviction setups daily — one momentum, one turnaround — filtered through tape structure, volume shifts, and misaligned narratives.
Some of these turn into full trades. A few evolve into deeper stories. The rest get cut.
This isn’t education. This is intelligence.
I don’t run ads. I don’t sell dreams. I track price, watch structure, and call bullshit when the story breaks.
Follow the setups. Fade the noise. Stick it to the man.
Let’s connect
Join!
Stay updated with our latest ideas by joining our newsletter.
Investment Gems 